These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14559101)

  • 21. Therapeutic antibodies and other proteins obtained by molecular display technologies.
    Shibasaki S; Ueda M
    Recent Pat Biotechnol; 2009; 3(1):19-27. PubMed ID: 19149719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic antibodies and antibody fusion proteins.
    Rohrbach P; Broders O; Toleikis L; Dübel S
    Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
    [No Abstract]   [Full Text] [Related]  

  • 23. Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.
    Almagro JC; Daniels-Wells TR; Perez-Tapia SM; Penichet ML
    Front Immunol; 2017; 8():1751. PubMed ID: 29379493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering antibody therapeutics.
    Chiu ML; Gilliland GL
    Curr Opin Struct Biol; 2016 Jun; 38():163-73. PubMed ID: 27525816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular engineering and design of therapeutic antibodies.
    Presta LG
    Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tailor-made antibody therapeutics.
    Chowdhury PS; Wu H
    Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.
    Loureiro LR; Carrascal MA; Barbas A; Ramalho JS; Novo C; Delannoy P; Videira PA
    Biomolecules; 2015 Aug; 5(3):1783-809. PubMed ID: 26270678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Engineering & Design 2010. 24-25 February 2010, Frankfurt, Germany.
    Beck A
    IDrugs; 2010 May; 13(5):295-9. PubMed ID: 20432182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies: technologies for early discovery and engineering.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of synthetic antibody libraries.
    Benhar I
    Expert Opin Biol Ther; 2007 May; 7(5):763-79. PubMed ID: 17477812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovering and improving novel peptide therapeutics.
    McGregor DP
    Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Engineering--IBC's 17th annual international conference. Antibody engineering and immunotherapeutics for the 21st century.
    Bradbury A
    IDrugs; 2007 Mar; 10(3):169-72. PubMed ID: 17351868
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering antibodies for cancer therapy.
    Boder ET; Jiang W
    Annu Rev Chem Biomol Eng; 2011; 2():53-75. PubMed ID: 22432610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and refolding technologies for production of recombinant proteins.
    Arakawa T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):231-2. PubMed ID: 20406165
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody engineering.
    Dall'Acqua W; Carter P
    Curr Opin Struct Biol; 1998 Aug; 8(4):443-50. PubMed ID: 9729735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering Antibodies for the Treatment of Infectious Diseases.
    Fan G; Li J
    Adv Exp Med Biol; 2017; 1053():207-220. PubMed ID: 29549641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research and development of next generation of antibody-based therapeutics.
    Li J; Zhu Z
    Acta Pharmacol Sin; 2010 Sep; 31(9):1198-207. PubMed ID: 20694021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-Based Cancer Therapy: Successful Agents and Novel Approaches.
    Hendriks D; Choi G; de Bruyn M; Wiersma VR; Bremer E
    Int Rev Cell Mol Biol; 2017; 331():289-383. PubMed ID: 28325214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.